CardioSignal
The company provides a CE-marked Class IIb medical device application that uses smartphone motion sensors and gyrocardiography to detect signs of atrial fibrillation in one minute. Its technology serves individual users for self-monitoring, healthcare providers for population health initiatives, and clinical professionals for point-of-care diagnostics. The software is validated by over a decade of academic research and is available across multiple European markets and the United Kingdom.
Visit websiteTurku, Finland
Healthtech
Medical Devices
Digital Health
Diagnostics
Funding summary
- Total raised
- €9.2M
- Funding rounds
- 1
Investors in CardioSignal
Investors on record for CardioSignal. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like CardioSignal?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors